Skip to content
RxE2 | Pharmacists Unbound
RxE2 | Pharmacists Unbound
  • Home
  • Services
    • Recruitment
    • Dispensing
    • Counseling
    • FAQs
  • Technology
    • Habitu
    • Trust Center
  • About
    • Team
    • News
    • Vision
  • Resources
  • Blog
  • Contact us
  • Pharmacies
Search:
  • Home
  • Services
    • Recruitment
    • Dispensing
    • Counseling
    • FAQs
  • Technology
    • Habitu
    • Trust Center
  • About
    • Team
    • News
    • Vision
  • Resources
  • Blog
  • Contact us
  • Pharmacies

News

Apr82025

Meet us in San Antonio at GCSG 2025!

MORE
Jan302025

[Press Release] Hawthorne Health and RxE2 Partner to Expand Patient Access in Clinical Trials

MORE
Jan272025

Meet our team at SCOPE 2025!

MORE
Nov302024

RxE2 named one of the best Tech Startups in North Dakota for the 3rd year in a row !

MORE
Feb82024

Step up your clinical trial game with RxE2 – Meet us in Philadelphia in April!

MORE
Oct82023

Meet our CEO at PharmSci360 in Florida!

MORE
Sep222023

RxE2 Once again named one of the best Tech Startups in North Dakota!

MORE
Aug232023

RxE2 welcomes Doug Liberi as Vice President of Business Development & Sales

MORE
Jun152023

RxE2 is proud to, once again, pledge $27,500 to NorthStar Development Cycling Club

MORE
Apr192023
Meet RxE2 at GCSG2023!

Meet us at GCSG 2023!

MORE
Dec122022

Meet RxE2 in San Francisco!

MORE
Oct202022

RxE2 announces investment from Badlands Capital

MORE
Oct92022
RxE2 Joins PQA

RxE2 Joins Pharmacy Quality Alliance

MORE
Sep172022
Meet RxE2 at NCPA 2022

Meet us at NCPA 2022

MORE
Jun22022

RxE2 welcomes David Stark as Senior Director of Business Development

MORE
Jun12022
RxE2 Northstar Development Cycling

RxE2 continues to support NorthStar Development Cycling Club

MORE
Apr152021

RxE2 Inc. Completes Acquisition of Habitu Ltd.

MORE
Feb22021
RxE2 Northstar Development Cycling

RxE2 CEO and Two-Time USA Cycling Masters Nationals Champion Gerald Finken Donates $27,500 to NorthStar Development Cycling Club

MORE
Jan112021
RxE2 acquires Habitu

RxE2 Agrees to Acquire Habitu to Form the First AI Driven, Pharmacist-Led, Clinical Trial Platform

MORE
Aug32020

RxE2 and Newdays Pharmacy Expand E2 Dispensing Service for Clinical Drug Trials to the EU and UK

MORE
Jul152020

RxE2 Names Tina Schlecht, Pharm. D., VP of Pharmacy Operations

MORE
Jul132020

RxE2 and Thrifty White Pharmacy Establish First E2 Dispensing Service for Clinical Drug Trials in the US

MORE
RxE2 is entirely revolutionizing how clinical trials are conducted by utilizing, for the first time ever, community pharmacists, powered by our cutting-edge technology that provides patient recruitment, dispensing, counseling, and operational services to the pharmaceutical and biotech industries. 
CONTACT US
(701)-492-2050 rxe2@rxe2.com 4302 13th Ave S Suite 4326 Fargo, ND 58103

Find us on:

YouTube page opens in new windowLinkedin page opens in new window
Copyright 2025 RxE2 Inc., All Rights Reserved
Terms of Use
Privacy Policy
Go to Top